Overview

Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg

Status:
Unknown status
Trial end date:
2018-11-09
Target enrollment:
Participant gender:
Summary
This study is an open-label, randomized, fasted, single-dose, 2-way crossover study to compare the pharmacokinetic characteristics and safety between CKD-380 10mg and D308 10mg in healthy male adults.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical